The molecule is currently undergoing Phase 1a clinical trials to evaluate its safety in patients with advanced solid tumors and healthy volunteers.
The molecule is currently undergoing Phase 1a clinical trials to evaluate its safety in patients with advanced solid tumors and healthy volunteers.